Evidence map›Paper›PMID 38987370›Full record

ArticleAnnals of surgical oncology2024

Comparing Costs: Does Extreme Oncoplastic Breast-Conserving Surgery Confer a Cost Benefit When Compared with Mastectomy and Reconstruction?

Janelle-Cheri Millen, Udai Sibia, Katherine Jackson, Stacey L Stern, Javier I J Orozco, Crystal E Fancher, Janie Grumley

Erratum issuedAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Janelle-Cheri MillenSaint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA. janellecheri@gmail.com.
Udai SibiaSaint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.
Katherine JacksonSaint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.
Stacey L SternDepartment of Biostatistics, Saint John's Cancer Institute, Providence Health System, Santa Monica, CA, USA.
Javier I J OrozcoSaint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.
Crystal E FancherSaint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.
Janie GrumleySaint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionExtreme oncoplastic breast-conserving surgery (eOBCS) describes the application of OBCS to patients who would otherwise need a mastectomy, and its safety has been previously described.

objectiveWe aimed to compare the costs of eOBCS and mastectomy.

methodsWe reviewed our institutional database to identify breast cancer patients treated surgically from 2018 to 2023. We included patients with a large disease span (≥5 cm) and multifocal/multicentric disease. Patients were grouped by their surgical approach, i.e. eOBCS or mastectomy. The direct costs of care were determined and compared; however, indirect costs were not included.

resultsEighty-six patients met the inclusion criteria, 10 (11.6%) of whom underwent mastectomy and 76 (88.4%) who underwent eOBCS. Six mastectomy patients (60%) had reconstruction and 6 (60%) underwent external beam radiation therapy (EBRT). Reconstructions were completed in a staged fashion, and the mean cost of the index operation (mastectomy and tissue expander) was $17,816. These patients had one to three subsequent surgeries to complete their reconstruction, at a mean cost of $45,904. The mean cost of EBRT was $5542. Thirty-four eOBCS patients (44.7%) underwent 44 margin re-excisions, including 6 (7.9%) who underwent mastectomy. Sixty (78.9%) of the eOBCS patients had EBRT. The mean cost of their index operation was $6345; the mean cost of a re-excision was $3615; the mean cost of their mastectomies with reconstruction was $49,400; and the mean cost of EBRT was $6807. The cost of care for eOBCS patients remained lower than that for mastectomy patients, i.e. $17,318 versus $57,416.

conclusioneOBCS is associated with a lower cost than mastectomy and had a low conversion rate to mastectomy.

Indexed as

Breast NeoplasmsCost-Benefit AnalysisMammaplastyMastectomy, SegmentalAdultAgedFemaleFollow-Up StudiesHumansMastectomyMiddle AgedPrognosisRetrospective StudiesBreast neoplasmCost-benefit analysisMastectomyOncoplastic breast-conserving surgery

Identifiers

PMID38987370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.